Just As In The Past, Marc Beer Is Once Again Leading A Company To Impressive Accomplishments:

Biotech and pharmaceutical industry business legend Marc Beer has built a career from helping people and leading companies to significant heights of success. He is also notable for his dedication to philanthropy. The career enjoyed by Marc Beer now spans more than thirty years and that time has seen him involved in major leadership roles as well as roles as a company founder. Recent years have seen him deeply involved in the most recent firm he has co-founded that is called Renovia. Marc Beer serves in this firm as its Chief Executive Officer and he is also the Chairman of the Board of Directors. 

 

With Renovia, Marc Beer is doing what he has done time and again in the past and working to help others to live better lives. In the case of this particular business venture, the focus is on finding new and innovative ways to better treat a condition that affects women known as the disorder of the pelvic floor. Marc has been using his tremendous resources and knowledge to grow this firm and he has established a truly outstanding team. He also recently put the firm through a Series B funding round which brought in a tremendous amount of money meant to be used in areas such as operating costs, and research into the development of new products. The first product that has come out from the Renovia team is Leva and it has already been approved by way of the FDA. This is a major feather in Marc Beer’s cap as far as the work he has done in quickly establishing this outstanding firm. This is by no means the first time that Marc Beer has managed to quickly grow a business that he has been involved with. The work he is doing with Renovia is typical of the type of success that he has become well known for. Learn more: https://www.bloomberg.com/research/stocks/people/person.asp?personId=1285777&privcapId=47636573

 

The first company of note that Marc Beer was involved in after his graduation from Miami University was a firm called Genzyme. This pharmaceutical firm was able to reach a much larger base of patients as a result of the work that Marc did as one of its Vice Presidents. He showed his impressive skills in the fields of marketing and sales during his tenure with Genzyme. The fact that he was able to help millions of people who were previously in a medically underserved situation also made a big impact on Marc Beer and this is something that has stayed with him over the years. 

 

Marc Beer took this experience with Genzyme and used it to help him build a company that he founded known as ViaCell. This firm did outstanding work in helping to facilitate vital research on stem cells collected from umbilical cord blood. This research was aimed at finding treatments for rare diseases. Marc Beer once again showed his ability to grow a business and from the 2000 founding to the year 2005, the company grew to include 300-plus employees. Marc Beer later sold the firm in 2007 for a substantial asking price. This was another example of the abilities that he continues to demonstrate in the work he is doing at Renovia.

Follow Marc Beer on Facebook

Marc Beer

Marc Beer Loves Helping the Underserved

Marc Beer’s career started with him helping the medically underserved. His first major job as Vice President of Global Marketing for Genzyme made his responsible for promoting product lines for over 7,000 rare diseases. Throughout his career at Genzyme, he reached more than 350 million people who fit into the category of “underserved.”

Inspired by his work with Genzyme, Beer decided to branch out on his own and found ViaCell. ViaCell collected and preserved umbilical cord blood stem cells, which is then used to develop treatments for a variety of conditions. The company was successful within five years and eventually sold for $300 million.

At the height of his career, he suffered a tragic loss. Shortly after selling ViaCell to PerkinElmer, his wife passed away suddenly. Distraught, he ended his entrepreneurial career and only focused on raising his three children. He found solace in being a full-time dad for the rest of his life but that wasn’t his destiny.

Beer would later find inspiration to relaunch his entrepreneurial career from his 14-year-old daughter. She started telling him he needed to “live with purpose;” something he’d been telling her every day for the last two years. Learn more: https://www.crunchbase.com/person/marc-beer

The other half of Beer’s destiny began years before he founded ViaCell. Dr. Ray Iglesias had been performing pelvic floor surgeries for 35 years, and in all that time, he always believed that surgery could be avoided. Before pelvic floor disorders only affect close to 25 percent of the women living in the U.S., most pharmaceutical and biotech companies weren’t developing any therapies or devices.

After 25 years of performing pelvic floor surgeries, he devoted the last ten of his 35-year career to helping women avoid the surgical option. When he finally felt his idea was developed enough, he brought the concept to Marc Beer.

With one phone call, Beer’s career was back on track. Inspired by his daughter and late wife, Beer focused all his effort on helping the women of America. In 2016, the duo brought in Yolanda Lorie and co-founded Renovia, a leader in developing therapeutic and diagnostic devices for women suffering from pelvic floor disorders.

Recently, the company reached its first major milestone by getting one of its products approved by the FDA. Renovia also recently landed some Series B funding in the amount of $32 million. With its first FDA-approved product, Leva, selling, the company also acquired an additional $10 million in revenue for funding.

Follow Marc Beer on Facebook

How Marc Beer Bounced Back

As the chairman, co-founder and CEO of Renovia, Marc Beer is no stranger to adversity in his career but many people are wondering how the 58-year-old businessman and entrepreneur has managed to stay on top all these years. He recently agreed to chat with Stephen Callahan about how he got to where he is today and where he hopes to go in the future of his career. He first started college in the autumn of 1983 where he realized he wanted to major in business. After graduating with a business degree in the spring of 1987, he then received his first job offer from a company called Abbott working in their sales department as one of their developers. He held this role for about six years before he moved on to Biostar where he worked in their marketing department.
After two years with the company, he accepted a position as the vice president of global marketing at a business known as Genzyme. He worked for the company for about four years before making the conscious decision to start his own business. Headquartered in Cambridge, Viacell was first
established in May of 2000 to analyze the blood stem cells of umbilical cords 
in order to try and uncover various vaccines and cures for a wide variety of diseases. He decided to go public with the company in 2005 and they had close to 500 employees but, not long afterward, they decided to close up shop and sell the company for a massive $300 million to Perkin Elmer.
Upon completion of the sale, he was all set to move on to his next big entrepreneurial venture but, before he could, there was a tragic death in the family as his wife passed away of a pulmonary embolism at the age of 42. After the funeral, he was forced to step up as the primary parent,
driving them to and from soccer practice,
 packing their lunches and helping them with schoolwork as per necessary. Two years later, however, his daughter made him realize the business world needed him and he resolved to open a new company called Renovia. Established in 2016, the
company is the brainchild of Dr. Ray Iglesias, Yolanda Lorie, and Beer and is dedicated to developing and producing medical products to help patients who are suffering from various conditions.

Learn more: https://blogwebpedia.com/marc-beer-entrepreneurial-spirit-biotech.html
This new venture has already been successful as the FDA just approved their first product for public use and they were awarded a $32 million grant continue researching and developing new products. In fact, some of the conditions they are currently attempting to treat affect nearly a
a quarter of the female population nationwide and this includes types of pelvic floor disorders.

Connect with Marc Beer on Facebook

Marc Beer Has Soldiered Through Adversity To Create High- Tech Medical Devices

As one of the most successful high-tech developers in the pharmaceutical and medical device sector, Marc Beer is quick to give credit to others. He said that none of the cutting-edge healthcare innovations he has introduced into the market would have been possible without the dedicated
people that made it happen.
Marc Beer believes that assembling teams and recognizing “good people” is a key to entrepreneurial achievement on a higher level. You not only have to recognize and surround yourself with the best staff, but you must also trust them and get out of their way so they can deliver results. If everyone shares a common goal and vision, Beer said, magical things can happen.
Marc Beer is the man behind a number of medical device innovations that have saved lives and help doctors treat patients for painful conditions. He began his career after graduating from Miami University in 1987 with a degree in business. His first job was in the pharmaceutical sector. He
accepted a position with Genzyme. There he worked his way up to Vice President of Global Marketing. It was an opportunity for Marc Beer to make global connections and gain deep insight into the realm of developing treatments and cures for diseases.
After his stint with Genzyme, Marc Beer was ready to create his own enterprise. This was ViaCell, launched in 2000. His approach was aggressive and relentless. ViaCell is a biotechnology company focused on the application of human cells as medicine for an array of treatment protocols. Within two years ViaCell has 300 employees. It went public in 2005 and is listed on the NASDAQ as VIAC. After seven years, Beer sold ViaCell for $300 million.
It should have been a time of triumph for Marc Beer, but life has a way of intervening. Not long after the sale of ViaCell, his wife tragically died at just age 42, struck by a pulmonary embolism. Marc Beer was left to raise his three children as a single father. It was a tremendously difficult time. Marc Beer needed to pause and re-evaluate his life and focus attention on the needs of three young children. Learn more: https://blogwebpedia.com/marc-beer-entrepreneurial-spirit-biotech.html
But it was one of his kids that prompted Marc Beer to get back into life. His 14-year-old daughter urged him to take on a new project. She reminded him about the thousands, if not millions of people his work had helped as the result of his work with Genzyme and creating ViaCell. His current project is another high-tech start-up, Renovia. This company is developing treatments for women suffering from painful disorders of the pelvis. Its first product, Leva, has just received approval by the FDA. Marc Beer is off and running with his next great success story.

Connect with Marc Beer on Facebook

Marc Beer

Marc Beer: The Importance of Illumination

During any surgical procedure, adequate illumination is the most important factor. Even the most experienced surgeon with the most skilled hands can cause irreparable damage to their patient and their career. For years, no one product has held the title of “most preferred by surgeons” when it comes to lighting.

One product most people think of when they think about illumination during surgeries is what they see in movies and on TV; one big light hanging over the operating table. While surgeons and doctors alike have used electric bulbs for many years, they never really liked to use them. Those giant electric bulbs were extremely bulky, they burned hot quickly and burned out, they offered poor illumination, and they consumed way too much energy.

Recently, LumeNXT, Inc. announced a new line of products that made the company’s new Chairman of the Board, Marc Beer, excited to be a part of the company. LumeNXT created a product line that combined white light-emitting diodes, micro-electronic switching technology, and compacted high-power batteries. Its new product line features small high-intensity non-tethered lighting sources.

That may all sound technical and boring, but to put in laymen’s terms, the company’s new lights will allow doctors and surgeons to place precision lighting into or on the edge of the surgical site. The notion of lighting from within has the entire medical industry up in a roar but in a good way. Everyone is excited to start working with an illumination source that can improve surgery safety and quickness.

These little lights are latex-free and come individually wrapped for convenience. They can only be used one time, but they required approximately one-twentieth of the energy required by the standard large electric bulbs, and they produce better lighting. They’re small enough to fit into a cavity, they produce no heat, and they’re inexpensive.

Marc Beer made a great choice for a new Chairman of the Board because he’s used to looking for and bringing new medical solutions to the field. One of his first companies was Renovia, Inc., a company dedicated to creating therapeutic and diagnostic devices for women suffering from pelvic floor disorder.

Though Renovia made Marc Beer an industry-known name, he also founded Minerva Neurosciences Inc., a company that looked for medicines that would help people suffering from schizophrenia, insomnia, and other mood disorders, including depressive disorders and Parkinson’s disease. Learn more: http://inspirery.com/interview-with-marc-beer/

Marc Beer Views on Technology and Leadership in Health Care

The medical world, especially medical investment is a unique niche in different ways. For example, the niche requires professionals that are not only inspired to solve human problems but also passionate for creating sustainable remedies for people around the globe. Marc Beer is a problem solver in this niche, and over the years, he has illustrated the importance of being inspired and passionate in the world of medical investment. In an interview with a popular medical journal, Beer also confessed that his two and a half decades in this niche has been a season for learning and more critically, a season for learning about his abilities and passions. 

 

Renovia — his latest outfit in his long and successful career — represents his passion for humanity and more specifically for women. He is a believer that women deserve more than what conventional medicine offers. Marc Beer — through a series of interactions with other industry players — has realized that there is a huge gap between the conventional medical options and the complications women have, as far as reproductive health is concerned. Through this start-up, he hopes to bring the best technology in creating different medical alternatives to medical professionals dealing with women reproductive health around the world. Learn more: https://www.crunchbase.com/person/marc-beer

 

In his long journey in creating solutions for women reproductive health, he has mastered the art of involving other industry players. Marc Beer understands that there is a need for more resources in this niche, and therefore, working with different investors and researchers is vital. Beer has a two-part criterion when bringing other people to his projects. First, the professional selected must have a similar view on reproductive health, and the similarity in opinions is a vital feature in the success of any project. Second, any potential entity must fit in his company’s description of a partner, where the value of life is irreplaceable.

 

Marc Beer is, however, more synonymous with his contributions to medical research and more importantly, research that involves women health. In Renovia, for example, he has taken his time to bring the best talents in research, especially on alternative medicine. He points out that research is what has revolutionized the medical world in the last 200 years, and it will be the main propeller to the next phase of medicine. In the past 36 months, he has invested his time in looking for the best researchers on different niches — and therefore making his company home to some of the best talents in this niche.

 

Lastly, he appreciates futuristic management, and as a founder to a medical start-up, he has brought the best administrators to his company. Marc Beer understands that although he has the best research minds in the world of alternative medicine, the company’s logistics determine the success of his company. 

Marc Beer

Marc Beer is the recently appointed new chairman of the board at LumeNXT, Inc. This company recognizes Beer’s significant impact on the health industry. He has successfully started up many companies, offering leadership and guidance that gives significant growth results to those specific corporations. He is an experienced and reputed biotechnologist with 25 years of experience in developing and commercializing pharmaceutical and biotechnology devices.

 

Additionally, Beer is the co-founder of Renovia, Inc, a company that enhances restorative and test procedures for women with pelvic-related issues. Situated in the state of Massachusetts, the company’s success is related to its formulation of digital devices for both diagnosis and treatment.

 

He also attributes to the significant contributions of societal well-being. He presently funded the women’s health startup at Renovia, Inc. through the raising of $42M. This company created diagnostic devices for pelvic floor disorders in women, and also therapeutic mechanisms for treating and relieving such-like ailments. The raised funds directed at the development and assessment of other four new products.

 

The co-founder of LumeNXT, Paul Rhyne, says that they are confident of Beer’s excellent contribution towards LumeNXT growth and betterment. He further states that Beer’s significant contributions to the global commercial initiations and further successes are sources of hope for the bright anticipated future of LumeNXT.

 

LumeNXT, Inc. is a private co-owned company that focuses on developing advanced surgical illumination products. Their focus is primarily on minimally invasive surgery. Beer is proud to join the LumeNXT group. He says that he is happy and anticipates working with the great team at LumeNXT. He further describes the group of workers at his newly-joined company as devoted, exceptional, and well-advanced in the surgical illumination sector.

 

Previously, Beer served as the CEO founder of ViaCell, which he joined in April 2000. This biotechnology company collects preserves and develops umbilical cord blood stem cells. Marc Beer’s leadership at ViaCell expanded the company to over 300 employees. It also received high publicity in 2005, before its ultimate acquisition by PerkinElmer in 2007.

 

Before, Beer served top positions at Genzyme, He had worked in different firms where he sharpened his skills and gained invaluable experiences. He was also the vice president at Global Marketing. His principal responsibility at Global Marketing was the launching and commercializing of a line of products which addresses rare illnesses amongst populations and at a global extent.

 

Beer, who was also the chairman of the compensation committee of Good Start Genetics, Inc. says that the minimally invasive surgery adopted by LumeNXT is a safe procedure due to its better visualization. Furthermore, he adds that people are yet to realize the significance of LumeNXT, and especially with the increase of more surgeries that will happen using the minimally invasive technology. Learn more: https://renoviainc.com/leadership/

 

Marc Beer Named New Chairman at LumeN XT

LumeN XT is a leading healthcare company that has recently made a new addition to its management team. The company recently named Marc Beer to serve as the new Chairman. With the naming of Marc Beer, LumeN XT will be adding one of the most successful executives in the healthcare industry. He brings 25 years of experience to the healthcare industry. Beer has spent much of his career developing and commercializing for biotechnology companies, pharmaceutical companies, medical devices and diagnostics. In his new leadership role at LumeN XT, Marc will help the company continue to reach its goals in advancing medical technology.

 

Once he was named as the new Chairman at LumeN XT, Marc Beer made a statement. In a recent discussion, Beer revealed that he is very happy to be working with renowned engineers and surgeons who are dedicated to advancing surgical illumination technology. Marc also said that the surgical illumination technology is very important to making surgery safer and should therefore be a priority in providing future medical treatment. Beer has said that LumeN XT will increase as more surgeries are performed in a less invasive manner.

 

Surgeons that have used illumination have found out that this technology provides a number of benefits. These include enhanced vision, more precision and increased flexibility during operations. Compared to other techniques, surgical illumination has proven to be more superior. LumeN XT currently offers an advanced illumination platform that includes a heat reduction mechanism. This improves the precision of surgical procedures along with providing low cost disposable options and safety with improved vision.

 

The founder of LumeN XT Paul Rhyne made a statement himself about the recent addition of Marc Beer. Rhyne revealed that Marc demonstrated a high level of success in terms of managing startup companies. Over the course of his career, Marc has helped the companies experience important phases of growth. Rhyme also said that the vast amount of experience of Marc has resulted in guiding startup companies in terms of global expansion and increased profitability. Learn more: https://renoviainc.com/leadership/

 

Marc Beer founded and serves as the top executive of Renovia Inc. Beer founded this company with a mission to provide solutions for women suffering from pelvic floor disorders. His company developed medical devices that provide therapy and diagnostics. During the past few years, Renovia has emerged as a leading medical technology company. Before he founded Renovia, Marc Beer was the Founding Chairman of Minerva Neurosciences. This company was a biopharmaceutical company that looked to treat a number of diseases of the central nervous system. This company conducted clinical trials as well as develop effective therapy options for conditions such as Parkinson’s Disease, insomnia, schizophrenia and depression. His success with these two companies has helped Marc establish lots of credibility as an entrepreneur and executive in the healthcare industry.

 

The Co-Founder, Chairman, and CEO at Renovia Inc., Marc Beer Raises Funds to Support Development of Women Pelvic Floor Treatment Products

Recently, Marc Beer, the Co-Founder of Renovia Inc. raised $42 million to fund women`s health startup at Renovia Center. Renovia Inc. is a Boston based health company that develops diagnostic and therapeutic devices for treating various pelvic floor disorders. The company was founded in August 2016, and the founding members were Ramon Iglesias, Marc Beer, and Yolanda Lorie and in the same year, they successfully closed Series A financing venturing with leading healthcare capital fund. Marc Beer has over 25 years of experience operating in the development and commercialization sectors.

 

Before Co-Founding Renovia Inc., Marc has established several other firms. In April 2000, Marc became the founding Chief Executive Officer of ViaCell. Under his management, the company increased to a robust commercial organization. ViaCell is a biotechnology company with a specialty in the collection, preservation, and development of umbilical cord stem cells.

 

Marc Beer closed Series B financing in two cycles, first one worth $32 million and second cycle worth $10 million in venture debt. The funding will be used in developing and testing four more therapeutic and diagnostic products as well as improving the new advanced Leva devices. Leva products were the first Renovia`s products, and in April they were approved by FDA. It is estimated that about 200 million women in the world suffer from pelvic floor disorders which includes urinary incontinence.

 

Series B financing round was led by advisors from New York and Missouri based Ascension Ventures. Longwood Fund, a healthcare investment group which previously had invested in Renovia also took part in Series B. On behalf of the company; Marc Beer appreciated the support received from leading healthcare investors who generously shares the company`s vision of helping women worldwide diagnose, treat and improve their lives. He added that through working together and combining innovative skills and proprietary sensor technologies as well as forming baseline factors with digital platform clients would receive the necessary information regarding pelvic disorders and also services will be offered at a relatively low price compared to other medical centers across the world.

 

Renovia Inc. management team are dedicated and values clients’ health as their priority. Marc Beer is the CEO although he operates with the help of other officials. Some of the top officials overseeing the smooth progress of Renovia include:

  1. William Dull, the Chief Commercial Officer. His major role is to oversee global commercial and company`s operation.
  2. Dr. Samantha Pulliam, MD who is the Chief Medical Officer. Previously she worked as Assistant professor of Obstetrics and Gynecology at the University of North Carolina.
  3. Jessica McKinney, PT, MS, CMPT. She is the Vice President of Medical Affairs and Clinical Advocacy.

Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html